Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06083324 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer

Study acronym: EXERT-C
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 26, 2026 to Jan 16, 2027
    • Study completion date: Jan 26, 2026 to Jan 16, 2028
    v4
  2. Primary completion date: Feb 3, 2025 to Jan 26, 2026
    • Study completion date: May 3, 2025 to Jan 26, 2026
    • Site contact updated
    v3
  3. Primary completion date: Feb 3, 2024 to Feb 3, 2025
    • Study completion date: May 3, 2024 to May 3, 2025
    • Interventions: Dose esclated resistance training (Other) to Dose escalated resistance training (Other)
    • Site contact updated
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
Trial Details
NCT Number NCT06083324
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions
(from sponsor)		 Cancer
Related terms Motor Activity, Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov